KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Income from Continuing Operations (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Income from Continuing Operations for 7 consecutive years, with 5425000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 19.51% to 5425000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 30439000.0 through Dec 2025, up 85.72% year-over-year, with the annual reading at 30439000.0 for FY2025, 85.72% up from the prior year.
  • Income from Continuing Operations hit 5425000.0 in Q4 2025 for GoodRx Holdings, up from 1119000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 58786000.0 in Q2 2023 to a low of 41734000.0 in Q3 2022.
  • Historically, Income from Continuing Operations has averaged 1006050.0 across 5 years, with a median of 1393500.0 in 2021.
  • Biggest YoY gain for Income from Continuing Operations was 4254.49% in 2023; the steepest drop was 1211.82% in 2023.
  • Year by year, Income from Continuing Operations stood at 39914000.0 in 2021, then skyrocketed by 95.06% to 1972000.0 in 2022, then plummeted by 1211.82% to 25869000.0 in 2023, then surged by 126.05% to 6740000.0 in 2024, then dropped by 19.51% to 5425000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for GDRX at 5425000.0 in Q4 2025, 1119000.0 in Q3 2025, and 12843000.0 in Q2 2025.